Meet the 2018 Health Visionary Award Winners
Colleen Conway-Welch, PhD
During her 29 years as dean of the Vanderbilt University School of Nursing, Dr. Colleen Conway-Welch shepherded an overhaul of school's curriculum, including the introduction of an accelerated master's program as well as PhD and Doctor of Nursing Practice (DNP) programs. She has served on the Board of the Society for Women's Health Research, as well as on President Ronald Reagan's Commission on the HIV Epidemic, the National Bipartisan Commission on the Future of Medicare, the Advisory Committee to the Director of the National Institutes of Health, and the HHS Secretary's Council on Public Health Preparedness, among many others. Most recently, she was recognized as a Living Legend by the American Academy of Nursing for her profound contributions to the nursing profession, health education and public policy.
Since beginning her career at Eli Lilly and Company in 1989, Christi Shaw has held positions of increasing influence and authority across the biopharmaceutical industry over three decades, including leadership positions at Lilly, Johnson & Johnson and Novartis. She rejoined Lilly in April 2017 as Senior Vice President and President of Lilly Bio-Medicines, leading Lilly's broadest therapeutic portfolio. Shaw has served on the boards of the Biotechnology Industry Organization (BIO), the Healthcare Leadership Council and the Young Women's Leadership Network. In May 2016, Shaw received Eye for Pharma's prestigious ``Lifetime Achievement Award`` for her industry thought leadership and dedication to the needs of patients. In 2017, Shaw founded the More Moments More Memories Foundation to assist people with cancer and their caregivers.
Janet Woodcock, MD
Since joining the Food and Drug Administration in 1986, Dr. Janet Woodcock has raised the standard of excellence in drug safety and patient care. She played a lead role in streamlining and ensuring transparency in the drug review process, helped to provide unprecedented opportunities for consumer and patient participation, as well as launched initiatives to improve drug safety management both within and outside the FDA. Dr. Woodcock has worked at the FDA's Center for Drug Evaluation and Research since 1994. From 2005 to 2008, she served the FDA's Commissioner, holding positions including Deputy Commissioner and Chief Medical Officer, Deputy Commissioner for Operations, and Chief Operating Officer. Before joining CDER, she served as Director of the Office of Therapeutics Research and Review and Acting Deputy Director in FDA's Center for Biologics Evaluation and Research.